Sleep tracking has moved beyond a wellness tool used by Quantified Selfers to a medical grade technology with the potential to create patient data that the sleep specialty has never had before. Insights from a growing body of longitudinal sleep data will not only help in the diagnosis and treatment of sleep disorders themselves, but in chronic diseases in which sleep disorders drive disease processes and compromise outcomes.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.Subscribe Free Premier Issue Learn More
Welcome to the August 7 edition of ‘Pathways’ Picks,’ our MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: CMS has been busy in the past week rolling out policy proposals. We spotlight a few key takeaways for medtech. And more to watch from China, the US, and Germany.Subscribe now to read the full analysis
Medical Alley Innovation Summit, September 11-12th, is next month. Register today to reserve your seat.Register Learn More
'Meet the Innovators' Season 2, Episode 9: A video interview with William Altman, CEO, and Christina Bolch, PhD, Sr Biomedical Engineer, CorInnova. Houston-based start-up, CorInnova Inc., is developing a minimally invasive soft robotic cardiac device that they anticipate will shift the paradigm of existing heart failure (HF) treatments, and may reverse the progression of HF or even prevent its development in post-heart attack patients.Subscribe now to read the full analysis